XSHE
000705
Market cap298mUSD
Jul 10, Last price
6.22CNY
1D
2.64%
1Q
-31.42%
Jan 2017
-52.41%
Name
Zhejiang Zhenyuan Share Co Ltd
Chart & Performance
P/E
91.58
P/S
0.91
EPS
0.07
Div Yield, %
0.99%
Shrs. gr., 5y
-0.42%
Rev. gr., 5y
-7.93%
Revenues
2.28b
-39.17%
Net income
23m
-34.66%
CFO
41m
-46.60%
Dividend
Jun 27, 20250.06 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in Shaoxing, China, Zhejiang Zhenyuan Share Co., Ltd. is a pharmaceutical entity with operations extending across China and into global markets. Established in 1752, the company provides a wide array of pharmaceutical offerings. These include various traditional Chinese medicines (such as patent medicines, raw materials, and herbal preparations), alongside modern chemical preparations, active pharmaceutical ingredients, biochemical compounds, anesthetics, psychotropic drugs, medical equipment, and chemical reagents. Its diverse product line is marketed under the Zhenyuan and Zhenyuantang brand names. The firm primarily caters to the pharmaceutical commerce and health service industries.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2020‑00 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||